Stem cell therapy ‘sold as a miracle cure’ linked to 17 bacterial hospitalizations

2-28-2019 unnamed file
Image credit: Liveyon

Over the past year, at least 17 people have been hospitalized after being injected with products made from umbilical cord blood, a little-known but fast-growing segment of the booming stem cell industry, according to state and federal health officials and patient reports. Sold as a miracle cure for a variety of in­trac­table conditions, the injections have sickened people in five states, prompting new warnings from health officials about the risks of unproven stem cell treatments.

All but two of the illnesses have been linked to a single company: Liveyon of Yorba Linda, Calif.

After obtaining 10 unopened vials of Liveyon treatments from clinics in Texas and Florida where patients had fallen ill, the CDC report said, investigators found bacteria in eight of them. In the weeks since then, CDC officials said, they have obtained many more ReGen vials directly from Liveyon and found bacteria in a large proportion of them.

Related article:  COVID-19 evolving to be less deadly? Experts challenge Italian doctor's claims

“We’re just the tip of the iceberg, and we’re the cleanest in the iceberg,” [Liveyon CEO John] Kosolcharoen said. “If anyone else knew what’s going on in this industry, they would roll over in their grave.”

Read full, original post: ‘Miraculous’ stem cell therapy has sickened people in five states

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend